Clinical trial
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung…
NCT00452634 · National Cancer Center, Korea, Other · Completed
Key facts
| NCT number | NCT00452634 |
|---|---|
| Title | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) |
| Official title | A Phase II Study of Irinotecan/Cisplatin Plus Simvastatin in Chemo-naive Patients With Extensive Disease-Small Cell Lung Cancer |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Irinotecan, Cisplatin, Simvastatin |
| Enrollment | 62 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Mar 27, 2007 |
| Last update posted | Jun 19, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: